DexCom, Inc. (DXCM) Financials

DXCM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 6.5 billion 3.8 billion
March 31, 2026 6.6 billion 3.7 billion
Dec. 31, 2025 6.3 billion 3.6 billion
Sept. 30, 2025 7.5 billion 4.8 billion

DXCM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 184.5 million 39.0 million
March 31, 2026 449.0 million 43.3 million
Dec. 31, 2025 192.1 million 35.0 million
Sept. 30, 2025 579.4 million 45.1 million

DXCM Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 249.1 million
March 31, 2026 199.5 million
Dec. 31, 2025 267.3 million
Sept. 30, 2025 283.8 million

DXCM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.9 billion 1.2 billion 155.6 million
March 31, 2026 2.4 billion 1.2 billion 143.0 million
Dec. 31, 2025 2.0 billion 1.2 billion 148.8 million
Sept. 30, 2025 3.3 billion 1.2 billion 128.8 million

DXCM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 391.8 million
March 31, 2026 393.6 million
Dec. 31, 2025 398.9 million
Sept. 30, 2025 407.4 million

DXCM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 84.7 million 153.0 million 358.7 million -
March 31, 2026 76.6 million 145.3 million 349.7 million -
Dec. 31, 2025 101.9 million 148.2 million 321.5 million -
Sept. 30, 2025 80.5 million 157.5 million 331.4 million -

DXCM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.3 billion 478.4 million
March 31, 2026 1.2 billion 441.6 million
Dec. 31, 2025 1.3 billion 466.9 million
Sept. 30, 2025 1.2 billion 477.9 million

DXCM

Price: $89.75

52 week price:
54.11
91.48

Earnings Per Share: 2.53 USD

P/E Ratio: 32.67

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 3.0 million

Ebitda: 6.3 million

Market Capitalization: 31.2 billion

Links: